Key result
POLARx cryoballoon maintains uniform pressure and sizing to theoretically optimize pulmonary vein occlusion in AF.
Why the study?
The cryoballoon catheter has been used for AF ablation for over a decade, but the recent introduction of the POLARx system with design changes requires review of its procedural implications.
Does the POLARx cryoballoon catheter improve procedural outcomes in patients with atrial fibrillation compared to the Arctic Advance cryoballoon?
Does the POLARx cryoballoon catheter improve procedural outcomes in patients with atrial fibrillation compared to the Arctic Advance cryoballoon?
The POLARx cryoballoon introduces novel design features intended to improve tissue contact and ablation efficacy during pulmonary vein isolation, though additional clinical data is needed to establish safety and optimal dosing.
Answers are grounded in this paper and cite their sources.
POLARx design may improve pulmonary vein occlusion in atrial fibrillation ablation; leaves open whether outcomes surpass prior cryoballoons without randomized trials.
PURPOSE OF REVIEW: The cryoballoon catheter has been an option for the treatment of atrial fibrillation for over a decade. The most widely used device is the Medtronic Arctic Advance cryoballoon catheter. Recently, Boston Scientific has released the POLARx cryoballoon catheter. Here we review the major changes in the catheter system's design and its implications for procedural practice. RECENT FINDINGS: The POLARx cryoballoon catheter has been approved for use in Europe. Some studies have been published detailing the first clinical experiences in vivo with this newest technology. SUMMARY: The changes to the POLARx cryoballoon catheter, particularly its ability to maintain balloon size and pressure, will improve occlusion and theoretically improve procedural outcomes.
No takes yet. Share an insight, caveat, or question.
WILBER W. SU (2021) conducted a review in Atrial fibrillation. POLARx cryoballoon catheter vs. Arctic Advance cryoballoon catheter was evaluated. The POLARx cryoballoon catheter features structural modifications that maintain constant pressure and uniform balloon size during ablation, theoretically improving pulmonary vein occlusion for the treatment of atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: